A Phase 2, Randomized, Human Growth Hormone-Controlled, Multicenter, Basket Study of Vosoritide in Children with Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome with an Inadequate Response to Human Growth Hormone
Primary Objective
A Phase 2, Randomized, Human Growth Hormone-Controlled, Multicenter, Basket Study of Vosoritide in Children with Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome with an Inadequate Response to Human Growth Hormone
Description
Phase 2, Randomized, Human Growth Hormone-Controlled, Multicenter, Basket Study
Details
Age
Child and Teen
Eligibility
Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency and Noonan Syndrome
Locations
Childrens Hospital Colorado
Principal Investigator
Shanlee Davis
Study ID
Protocol Number: 24-1710
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers